Results 141 to 150 of about 1,053,112 (188)

Immunohistochemical Validation and Expression Profiling of NKG2D Ligands in a Wide Spectrum of Human Epithelial Neoplasms

Journal of Histochemistry and Cytochemistry, 2015
Hiromi Fujita, Y. Hatanaka, Y. Sutoh, Yuhsuke Suzuki, K. Oba, K. Hatanaka, T. Mitsuhashi, N. Otsuka, K. Fugo, M. Kasahara, Y. Matsuno   +10 more
semanticscholar   +1 more source

Rapamycin downregulates NKG2D ligands in acute myeloid leukemia cells via an activation of the STAT3 pathway: a potential mechanism for rapamycin-induced immune escape in leukemia. [PDF]

Transl Cancer Res, 2019
Zhu Z, Bai Y, Lu X, Ding J, Qi C.
europepmc   +1 more source

Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies-a narrative review. [PDF]

Transl Cancer Res
Zheng Y, Ding W, Chen B, Geng C, Li X.
europepmc   +1 more source

Interaction of CD99 and its ligands regulates immunoregulatory pathways in NK cells. [PDF]

Front Immunol
Thu MM, Takheaw N, Laopajon W, Kasinrerk W, Pata S.   +4 more
europepmc   +1 more source

Insights into ectodomain shedding as a novel target in natural killer cell-based immunotherapy for cancer. [PDF]

Front Immunol
Pimenta R, Arai J, Ribeiro de Lima Brandao L, Schmidt P, da Silva Bortoleti BT, Ferrari de Andrade L.   +5 more
europepmc   +1 more source

Interaction between NKG2D and its ligands MICA/B activates the DAP12/SYK/p53/p21 axis to drive pulmonary fibrosis. [PDF]

Front Immunol
Zhao C, Ren H, Ke Q, Chen Q, He J, Tian R, Pan H, Liu L.   +7 more
europepmc   +1 more source

Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy. [PDF]

Front Immunol
Zhang R, Ma P, Tang K, Cao Y, Yang Y, Hao S, Li T, Peng X.   +7 more
europepmc   +1 more source

Resting-state spatial statistics of NK cell receptors may improve early signal discrimination. [PDF]

Biophys J
Ahmad S, Mukhopadhyay D, Grewal RK, Jayaprakash C, Das J.   +4 more
europepmc   +1 more source